Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Dal Pan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Annals of Pharmacotherapy|May 7, 2019
Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting SystemMohamed Mohamoud, Saharat Patanavanich, Page Crew, et al.
Anesthesiology|March 21, 2018
New Opioid Analgesic Approvals and Outpatient Utilization of Opioid Analgesics in the United States, 1997 through 2015Grace Chai, Jing Xu, James Osterhout, et al.
Pharmacoepidemiology and Drug Safety|July 28, 2010
Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008Ann W McMahon, Robert G Pratt, Tarek A Hammad, et al.
Annals of Internal Medicine|March 12, 2019
Graphical Depiction of Longitudinal Study Designs in Health Care DatabasesSebastian Schneeweiss, Jeremy A Rassen, Jeffrey S Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virusAlfred Sorbello, S Christopher Jones, Wendy Carter, et al.
Drug Safety|December 2, 2022
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 PandemicIda-Lina Diak, Kimberley Swank, Kate McCartan, et al.
NPJ Digital Medicine|December 21, 2021
Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis frameworkRishi J Desai, Michael E Matheny, Kevin Johnson, et al.
BMJ (Clinical Research Ed.)|February 12, 2024
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation CenterRishi J Desai, Shirley V Wang, Sushama Kattinakere Sreedhara, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Annals of Pharmacotherapy|May 7, 2019
Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting SystemMohamed Mohamoud, Saharat Patanavanich, Page Crew, et al.
Anesthesiology|March 21, 2018
New Opioid Analgesic Approvals and Outpatient Utilization of Opioid Analgesics in the United States, 1997 through 2015Grace Chai, Jing Xu, James Osterhout, et al.
Pharmacoepidemiology and Drug Safety|July 28, 2010
Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008Ann W McMahon, Robert G Pratt, Tarek A Hammad, et al.
Annals of Internal Medicine|March 12, 2019
Graphical Depiction of Longitudinal Study Designs in Health Care DatabasesSebastian Schneeweiss, Jeremy A Rassen, Jeffrey S Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virusAlfred Sorbello, S Christopher Jones, Wendy Carter, et al.
Drug Safety|December 2, 2022
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 PandemicIda-Lina Diak, Kimberley Swank, Kate McCartan, et al.
NPJ Digital Medicine|December 21, 2021
Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis frameworkRishi J Desai, Michael E Matheny, Kevin Johnson, et al.
BMJ (Clinical Research Ed.)|February 12, 2024
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation CenterRishi J Desai, Shirley V Wang, Sushama Kattinakere Sreedhara, et al.
Pageof 4